The competition for the European CIVIS Media Prize is now open. European programmes on addressing migration, integration, cultural diversity and – linked to this – social cohesion can be submitted up to and including 19 January 2022. The CIVIS Media Prize honours outstanding TV, radio and online productions that promote peaceful coexistence between people from… Read More »
For decades, Jacobus Pharmaceuticals gave away the unapproved drug amifampridine to patients with a rare neuromuscular disorder called LEMS. Then, Catalyst Pharma licensed certain rights to the drug, scored an FDA nod, and priced the med at $ 375,000 a year. An outcry ensued. But now, the FDA may have given patients a workaround. Jacobus… Read More »
By ADRIAN GROPPER, MD Many of you have received the email: Microsoft HealthVault is shutting down. By some accounts, Microsoft has spent over $ 1 Billion on a valiant attempt to create a patient-centered health information system. They were not greedy. They adopted standards that I worked on for about a decade. They generously funded… Read More »
By KATHERINE HEMPSTEAD PhD The 2019 ACA plan year is notable for the increase in insurer participation in the marketplace. Expansion and entry have been substantial, and the percent of counties with one insurer has declined from more than 50 percent to approximately 35 percent. While urban areas in rural states have received much of… Read More »